Awan FT, Yande S, Esterberg L, Nagar SP, Goyal RK, Priyadarshini M. Economic burden in patients (pt) with CLL/SLL (CLL) who received ≥ 2 prior lines of therapy (LOT), including a Bruton tyrosine kinase inhibitor (BTKi): a SEER-Medicare analysis. Poster presented at the ASCO Quality Care Symposium 2023; October 27, 2023. Boston, MA. [abstract] JCO Oncol Pract. 2023 Nov 1; 19(11 Suppl):23-4. doi: 10.1200/OP.2023.19.11_suppl.24
Gnanasakthy A, Norcross L, Clark M, Fitzgerald K. A review of patient-reported outcome considerations in oncologic drug advisory committee meetings (2016-2021). JCO Oncol Pract. 2023 May;19(5):e745-62. doi: 10.1200/OP.22.00774
Morris A, Samsell B, Dorsch K, McLean J, Moore M, Fox T, Roth C. Use of acellular dermal matrix for reconstruction of massive rotator cuff tears in an older population. Orthop Muscular Syst. 2018 Nov 1;7(4):1000261. doi: 10.4172/2161-0533.1000261
Sebastian J, Cai L, Williamson D, Foushee B, Kam-Morgan L, Eisenberg MT. Identification and characterization of two novel sequence variants in the Thrombopoietin Receptor (MPL) gene using data from 8700 JAK-2 V617F negative patients. Poster presented at the 2016 Association for Molecular Pathology (AMP) Annual Meeting; November 10, 2016. Charlotte, NC. [abstract] J Mol Diagn. 2016 Nov; 18(6):955. doi: 10.1016/S1525-1578(16)30176-3